Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Melotek

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Oligometastasis-Directed Ablative Therapy: A Clinical Trial QuestionJames M Melotek, Steven J Chmura
Plos One|October 30, 2015
Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual OutcomesJames M Melotek, Chuanhong Liao, Stanley L Liauw
The International Journal of Cardiovascular Imaging|May 5, 2011
A middle mediastinal tumorAndrew L Rivard, Robert P Gallegos, James M Melotek, et al.
Advances in Oto-Rhino-Laryngology|July 31, 2020
Update of Radiation Techniques Using Photons for Anterior Skull Base TumorsCorey C Foster, Joseph K Kim, James M Melotek, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|November 25, 2016
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancerJames M Melotek, Benjamin T Cooper, Matthew Koshy, et al.
Practical Radiation Oncology|March 11, 2016
Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancerChristina H Son, James M Melotek, Chuanhong Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2020
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional OutcomesCorey C Foster, Tanguy Y Seiwert, Ellen MacCracken, et al.
Oral Oncology|May 1, 2018
Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experienceCorey C Foster, James M Melotek, Ryan J Brisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck CancerTanguy Y Seiwert, James M Melotek, Elizabeth A Blair, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Oligometastasis-Directed Ablative Therapy: A Clinical Trial QuestionJames M Melotek, Steven J Chmura
Plos One|October 30, 2015
Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual OutcomesJames M Melotek, Chuanhong Liao, Stanley L Liauw
The International Journal of Cardiovascular Imaging|May 5, 2011
A middle mediastinal tumorAndrew L Rivard, Robert P Gallegos, James M Melotek, et al.
Advances in Oto-Rhino-Laryngology|July 31, 2020
Update of Radiation Techniques Using Photons for Anterior Skull Base TumorsCorey C Foster, Joseph K Kim, James M Melotek, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|November 25, 2016
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancerJames M Melotek, Benjamin T Cooper, Matthew Koshy, et al.
Practical Radiation Oncology|March 11, 2016
Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancerChristina H Son, James M Melotek, Chuanhong Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2020
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional OutcomesCorey C Foster, Tanguy Y Seiwert, Ellen MacCracken, et al.
Oral Oncology|May 1, 2018
Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experienceCorey C Foster, James M Melotek, Ryan J Brisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck CancerTanguy Y Seiwert, James M Melotek, Elizabeth A Blair, et al.
Pageof 2